Tell us what you think about Healio
Sign in for a personal experience.
Customized content served to meet your interests.
Results from the randomized, double blind, placebo-controlled REMIT trial suggest that 6 weeks of treatment with the antidepressant escitalopram — a selective serotonin reuptake inhibitor — was associated with a significant reduction in the rate of mental stress-induced myocardial ischemia among patients with stable CHD.
“Recent evidence suggests that selective serotonin reuptake inhibitors (SSRIs) may reduce mental stress-induced hemodynamic response, metabolic risk factors, and platelet reactivity,” researchers wrote in a study published in JAMA.
Register for Healio to get content tailored to your specialty and areas of interest.
It’s FREE and only takes one minute.
View past polls »
©2013 All Rights Reserved.